CalciMedica, Inc. CALC

NAS: CALC | ISIN: US38942Q2021   7/08/2025
2,910 USD (-3,00%)
(-3,00%)   7/08/2025

8 juli 2025 · CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference · Persbericht

25 juni 2025 · CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure · Persbericht

12 juni 2025 · CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting · Persbericht

14 mei 2025 · CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates · Persbericht

17 april 2025 · CalciMedica Announces Presentations at Upcoming Medical Meetings · Persbericht

1 april 2025 · CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference · Persbericht

27 maart 2025 · CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates · Persbericht

5 maart 2025 · CalciMedica Secures Credit Facility for Up to $32.5 Million · Persbericht

4 maart 2025 · CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference · Persbericht

3 september 2024 · CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference · Persbericht

12 augustus 2024 · CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates · Persbericht

9 juli 2024 · CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI) · Persbericht

8 juli 2024 · CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences · Persbericht

1 juli 2024 · CalciMedica Set to Join Russell Microcap® Index · Persbericht

27 juni 2024 · CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) · Persbericht

26 juni 2024 · CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) · Persbericht

13 mei 2024 · CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates · Persbericht

7 mei 2024 · CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 · Persbericht

24 april 2024 · CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis · Persbericht

28 maart 2024 · CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates · Persbericht

Mijn selecties